Usana Health Sciences, Inc. balance sheet USNA

Annual Quarterly

As of Jul 4, 2026, Usana Health Sciences, Inc. had total assets of $703.2 million and total liabilities of $132.2 million. Total assets were down 4.3% from a year earlier. Stockholders' equity was $526.3 million. Cash and investments were $168.6 million. The current ratio, current assets divided by current liabilities, was 2.66.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2026 Jul 4, 2026	FY 2025 Jan 3, 2026	FY 2023 Dec 28, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 31, 2022	FY 2022 Jan 1, 2022	FY 2020 Jan 2, 2021	FY 2019 Dec 28, 2019	FY 2018 Dec 29, 2018	FY 2017 Dec 30, 2017	FY 2016 Dec 31, 2016
Assets
Cash	169 +11.4%	158	182 -24.2%	330 +37.8%	288	240	312 +32.8%	235 +9.6%	214 -13.3%	247 +40.6%	176 +22.7%
Cash and investments	169 +11.4%	158	182 -24.2%	330 +37.8%	288	240	312 +32.8%	235 +9.6%	214 -13.3%	247 +40.6%	176 +22.7%
Receivables	3	—	—	—	—	—	—	—	—	—	—
Inventory	86 +3.7%	103	70 -29.1%	61 -37.5%	67	98	90 +30.9%	69 -15.9%	82 +30.2%	63 -2.9%	65 -2.0%
Total current assets	281 +7.3%	288	279 -23.5%	418 +14.4%	384	365	425 +29.2%	329 -16.1%	392 +15.3%	340 +22.4%	278 +13.8%
Property and equipment, net	94 -2.3%	94	95 -7.1%	100 -1.9%	98	102	100 +5.5%	95 +3.5%	92 -10.5%	103 +1.6%	101 +15.1%
Goodwill	109 -24.3%	138	144 +716.0%	17 -3.2%	17	18	17 +4.4%	17 -1.1%	17 -3.5%	17 +4.2%	17 -4.1%
Total assets	703 -4.3%	743	748 +29.5%	633 +9.5%	597	578	641 +24.0%	517 -6.8%	554 +6.8%	519 +10.3%	471 +11.2%
Liabilities and equity
Accounts payable	15 -13.8%	17	12 -11.3%	10 -25.5%	11	14	18 +45.3%	13 +25.9%	10 -15.6%	12 +30.4%	9 -10.0%
Total current liabilities	106 -13.1%	129	140 -13.2%	119 -26.1%	144	161	168 +23.5%	136 -8.5%	149 +5.3%	141 +1.9%	138 +5.4%
Total liabilities	132 -11.2%	157	162	—	—	—	—	—	—	—	—
Stockholders' equity	526 -0.9%	533	532 +34.7%	497 +25.8%	434	395	442 +25.6%	352 -10.1%	391 +7.7%	363 +11.7%	325 +15.8%
Debt
Lease liabilities	—	18	16 -6.3%	12 -28.2%	15	17	—	26	—	—	—
Total debt	—	18	16 -6.3%	12 -28.2%	15	17	—	26	—	—	—
Net cash	—	140	166 -25.6%	318 +42.9%	274	223	—	209	—	—	—
Ratios
Current ratio	2.66x	2.24x	2.00x	3.52x	2.67x	2.27x	2.53x	2.42x	2.64x	2.41x	2.01x
Debt to equity	—	0.03x	0.03x	0.02x	0.03x	0.04x	—	0.07x	—	—	—
Debt to EBITDA	—	0.26x	0.15x	0.12x	0.12x	0.14x	—	0.16x	—	—	—
Return on equity	-4.21%	2.02%	11.99%	12.83%	15.96%	17.55%	28.23%	28.58%	32.27%	17.22%	30.75%
Return on assets	-3.15%	1.45%	8.53%	10.08%	11.63%	12.00%	19.45%	19.45%	22.77%	12.04%	21.26%
Book value per share	28.51	29.16	27.91	25.99	22.62	20.37	20.99	16.24	16.60	15.12	13.29

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: USNA (NYSE)
Fiscal year ends: January 3
Incorporated in: UT
Headquarters: Salt Lake City, UT
SEC filer status: Accelerated filer
SEC CIK: 896264
Former names: USANA INC (until Apr 27, 2000)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.